Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 2/20 | 0.39 |
| ▸ | MMP3 | P08254 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5063316 | 1.00 | GPR84 (0.42) | GPR84CA2FFAR1FFAR4FAAH | |
| SCHEMBL2374648 | 1.00 | GPR84 (0.42) | GPR84CA2FFAR1FFAR4FAAH | |
| SCHEMBL8109186 | 0.92 | FAAH (0.46) | FFAR1FFAR4FAAH | |
| SCHEMBL29205058 | 0.89 | CA2 (0.41) | GPR84CA2FFAR1PSMD14PLA2G1B | |
| SCHEMBL29205059 | 0.89 | CA2 (0.41) | GPR84CA2FFAR1PSMD14PLA2G1B | |
| SCHEMBL29205057 | 0.89 | CA2 (0.41) | GPR84CA2FFAR1PSMD14PLA2G1B | |
| SCHEMBL8109755 | 0.85 | USP2 (0.48) | CA2BIRC2 | |
| SCHEMBL8109149 | 0.85 | USP2 (0.48) | CA2BIRC2 | |
| SCHEMBL8108513 | 0.83 | GNAI3 (0.50) | CA2BIRC2 | |
| SCHEMBL8109579 | 0.83 | GNAI3 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514806-B2 | Cosmetic composition comprising ceramides and sphingolipid | CRODA KOREA LTD. (KR) | 2026-01-06 | — | — | US | disclosed |
| US-20240225987-A9 | LIQUID CRYSTAL COMPOSITION INCLUDING CERAMIDE AND METHOD OF PREPARING THE SAME | CRODA KOREA LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240173240-A1 | COSMETIC COMPOSITION COMPRISING CERAMIDES AND SPHINGOLIPID | CRODA KOREA LTD (KR) | 2024-05-30 | — | — | US | disclosed |
| CN-117942280-A | Liquid crystal composition comprising ceramide and preparation method thereof | 禾大韩国有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117942279-A | Cosmetic composition comprising ceramide and sphingolipid | 禾大韩国有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20240130950-A1 | LIQUID CRYSTAL COMPOSITION INCLUDING CERAMIDE AND METHOD OF PREPARING THE SAME | CRODA KOREA LTD (KR) | 2024-04-25 | — | — | US | disclosed |
| EP-4356898-A1 | COSMETIC COMPOSITION COMPRISING CERAMIDES AND SPHINGOLIPID | Croda Korea Limited (KR) | 2024-04-24 | — | — | EP | disclosed |
| EP-4356895-A1 | LIQUID CRYSTAL COMPOSITION INCLUDING CERAMIDE AND METHOD OF PREPARING THE SAME | Croda Korea Limited (KR) | 2024-04-24 | — | — | EP | disclosed |
| US-11166899-B2 | Composition for external application containing a ceramide, a derivative thereof and an extract of Hibisci cortex | AMOREPACIFIC CORPORATION (KR) | 2021-11-09 | — | — | US | disclosed |
| US-20200179260-A1 | COMPOSITION FOR EXTERNAL APPLICATION CONTAINING A CERAMIDE, A DERIVATIVE THEREOF AND AN EXTRACT OF HIBISCI CORTEX | AMOREPACIFIC CORPORATION (KR) | 2020-06-11 | — | — | US | disclosed |
| US-6060612-A | SKIN CARE COSMETIC | PACIFIC CORPORATION (KR) | 2000-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11166899-B2 | Composition for external application containing a ceramide, a derivative thereof and an extract of Hibisci cortex | CERT1, CERS2, SGMS1 | GPR84 3449/4885CA2 3130/4885FFAR1 1991/4885 |
| US-20200179260-A1 | COMPOSITION FOR EXTERNAL APPLICATION CONTAINING A CERAMIDE, A DERIVATIVE THEREOF AND AN EXTRACT OF HIBISCI CORTEX | CERT1, CERS2, SGMS1 | GPR84 3449/4885CA2 3130/4885FFAR1 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.